biomarkers
Biomarker‑Driven Supplement Protocols Cut 12‑Month Relapse Rates in Chronic Disease
A 2026 rheumatoid arthritis trial linked biomarker panels to relapse risk, suggesting that timed supplementation could reduce 12‑month recurrence. We explain the mechanism and give a 10‑day self‑study plan.